Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer [Phase 1]
Phase 1 trial evaluating cirmtuzumab in combination with paclitaxel for metastatic or locally advanced, unresectable breast cancer has compl…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer [Phase 1]
This is an update on a Phase 1 study of AZD9833 in Japanese women with ER-positive, HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating rifaximin to treat gastrointestinal toxicities related to pertuzumab-based therapy in patients with stage …
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer [Phase 2]
A Phase 2 trial evaluating SKB264 in combination with KL-A167 as neoadjuvant therapy for early-stage, high-risk ER+/HER2- breast cancer; the…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™ [NA]
Trial update on Xperience™, a novel surgical irrigation solution, evaluating its use in post-mastectomy reconstruction to reduce surgical si…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial [Phase 2]
Phase 2 genotyping-based trial evaluating talazoparib in patients with somatic BRCA-mutant metastatic breast cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Psychological Distress in Breast Cancer Patients: A Cross-Sectional Study in Iraq
A completed cross-sectional study conducted in Iraq examines psychological distress in breast cancer patients. The study reports on prevalen…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: ESPB Versus Perioperative Iv Lidocaine Infusion on Proinflammatory Cytokines in Breast Cancer Surgeries [NA]
This trial compares erector spinae plane block (ESPB) versus perioperative intravenous lidocaine infusion in breast cancer surgery to assess…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth [NA]
An ongoing clinical trial in Greece evaluating a manualized post-traumatic growth intervention for cancer patients; the study is currently r…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Adjustable Compression Wraps (ACW) in Lymphedema [NA]
A completed clinical trial evaluated Adjustable Compression Wraps for lymphedema, including arm lymphedema and breast-cancer–associated case…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Real-life Pan-HER-blockade With Neratinib
This clinical trial update reports a completed real-world study of neratinib used for pan-HER blockade in breast cancer.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer
Real-world genomic data study to inform next-treatment decisions in metastatic breast cancer; the study is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer [Phase 3]
A Phase 3 trial is evaluating GM1 as a preventive treatment to reduce nab-paclitaxel–associated chemotherapy-induced peripheral neuropathy i…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy [NA]
This clinical trial update describes a study comparing carbon suspension versus a metallic marker for axillary lymph node marking in breast …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer [NA]
This clinical trial update describes a study to assess whether prolonged overnight fasting and/or exercise affects fatigue and other patient…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Evaluation of Improvements in Patient-reported Quality of Life [NA]
Clinical trial evaluating patient-reported quality of life in breast cancer patients; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain
A completed qualitative study sponsored by Gilead Sciences examining advanced breast cancer patients and their caregivers in Spain.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Messaging Intervention to Increase Medicare Annual Wellness Visits -- The NUDGE AWV Clinical Trial [NA]
The trial evaluated a messaging intervention to increase Medicare Annual Wellness Visits and cancer screenings (breast and colorectal) and i…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC [Phase 2]
A prospective multicenter Phase 2 single-arm trial evaluating AK112 plus nab-paclitaxel and carboplatin as neoadjuvant therapy for triple-ne…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy. [Phase 2]
This clinical trial update outlines a Phase 2 study from Hebei Medical University Fourth Hospital to optimize neoadjuvant therapy for HER2-p…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
This clinical trial update describes a formative evaluation to improve breast cancer hormone receptor testing in Tanzania, and it is current…
-
FDA approval · 2025-08-05FDA Approved: ERIBULIN MESYLATE — Original Application (Kindos Pharmaceuticals Co., Ltd.)
FDA approves an original application for Eribulin Mesylate from Kindos Pharmaceuticals Co., Ltd., enabling its generic product to enter the …
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Systematic Intervention to Improve Sexual Dysfunction [NA]
A clinical trial is currently RECRUITING to test a systematic intervention aimed at improving sexual dysfunction in patients with breast can…
-
EMA approval · 2025-08-04EMA Authorised: Docetaxel Kabi (docetaxel) — Fresenius Kabi Deutschland GmbH
The EMA authorised Docetaxel Kabi (docetaxel) from Fresenius Kabi Deutschland GmbH for multiple cancer indications, including head and neck …
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study evaluating a 3D-printed personalized biodegradable implant for bre…